94.47
-0.145(-0.15%)
Currency In USD
| Previous Close | 94.62 |
| Open | 95.77 |
| Day High | 96.06 |
| Day Low | 91.52 |
| 52-Week High | 101.4 |
| 52-Week Low | 51.79 |
| Volume | 2.25M |
| Average Volume | 1.77M |
| Market Cap | 12.64B |
| PE | 30.57 |
| EPS | 3.09 |
| Moving Average 50 Days | 84.1 |
| Moving Average 200 Days | 66.97 |
| Change | -0.14 |
If you invested $1000 in Globus Medical, Inc. (GMED) 10 years ago, it would be worth $3,733.99 as of January 11, 2026 at a share price of $94.47. Whereas If you bought $1000 worth of Globus Medical, Inc. (GMED) shares 5 years ago, it would be worth $1,413.16 as of January 11, 2026 at a share price of $94.47.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma
GlobeNewswire Inc.
Oct 14, 2025 8:40 PM GMT
AUDUBON, Pa., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, has announced the launch of the ANTHEM™ Elbow Fracture System, a fully comprehensive plating portfolio designed to addre
Globus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigation Against Life Spine, Inc.
GlobeNewswire Inc.
Aug 28, 2025 8:30 PM GMT
AUDUBON, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, announced that a Delaware jury has returned a verdict in favor of Globus in its patent infringement litigation against
Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results
GlobeNewswire Inc.
Jul 21, 2025 12:00 PM GMT
AUDUBON, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced that Keith Pfeil, Executive Vice President, Chief Operating Officer and Chief Financial Officer, has be